These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4671960)

  • 1. Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.
    Bonagura V; Cassebaum L; Dangman K; Freund J; Cabbat F; Dembiec D; Heikkila R; Cohen G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):163-71. PubMed ID: 4671960
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 3. Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol.
    Cohen G; Heikkila RE; Allis B; Cabbat F; Dembiec D; MacNamee D; Mytilineou C; Winston B
    J Pharmacol Exp Ther; 1976 Nov; 199(2):336-52. PubMed ID: 185360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isomers of 2,4,5-trihydroxyphenethylamine (6-hydroxydopamine): long-term effects on the accumulation of (3H)-norepinephrine in mouse heart in vivo.
    Lundstrom J; Ong H; Daly J; Creveling CR
    Mol Pharmacol; 1973 Jul; 9(4):505-13. PubMed ID: 4725781
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of 6-hydroxydopamine on vagal cardioaccelerator systems.
    Alter WA; Weiss GK; Priola DV; Spurgeon HA
    J Pharmacol Exp Ther; 1973 Oct; 187(1):99-104. PubMed ID: 4746337
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the possibility of chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine (6-OH-DA)].
    Thoenen H; Tranzer JP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):212-3. PubMed ID: 4239240
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake and accumulation of 3H-6,7-dihydroxytetrahydroisoquinoline by peripheral sympathetic nerves in vivo.
    Locke S; Cohen G; Dembiec D
    J Pharmacol Exp Ther; 1973 Oct; 187(1):56-67. PubMed ID: 4746334
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté L; Cohen G
    J Neurochem; 1973 May; 20(5):1345-50. PubMed ID: 4716829
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of nicotine by the sympathetic nerve terminals in the blood vessel.
    Bevan JA; Su C
    J Pharmacol Exp Ther; 1972 Sep; 182(3):419-26. PubMed ID: 5055404
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of 6-hydroxydopamine neurotoxicity.
    Cohen G; Allis B; Winston B; Mytilineou C; Heikkila R
    Eur J Pharmacol; 1975 Aug; 33(1):217-21. PubMed ID: 1175689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake, retention and metabolism of H 3 -tyramine in rat atria.
    Steinberg MI; Smith CB
    J Pharmacol Exp Ther; 1971 Jan; 176(1):139-48. PubMed ID: 4936457
    [No Abstract]   [Full Text] [Related]  

  • 13. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
    Jonsson G; Sachs C
    J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative histofluorescent study of cardiac sympathetic nerves and adrenal catecholamines in rats under immobilization stress and administered a toxic dose of noradrenaline].
    Serov RA; Chekareva GA; Sokolova NN; Mikhaĭlenko TF
    Farmakol Toksikol; 1987; 50(4):38-41. PubMed ID: 3666114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle and gland cell degeneration in the octopus posterior salivary gland after 6-hydroxydopamine administration.
    Martin R; Barlow JJ
    J Ultrastruct Res; 1975 Aug; 52(2):167-78. PubMed ID: 1152112
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.
    Finch L; Haeusler G; Kuhn H; Thoenen H
    Br J Pharmacol; 1973 May; 48(1):59-72. PubMed ID: 4724194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic nerve cultures as a tool for the pharmacological study of sympathetic terminals.
    Mottram DR; Presley R; Lever JD; Ivens C
    Eur J Pharmacol; 1973 May; 22(2):175-80. PubMed ID: 4146007
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of 6-hydroxydopamine.
    Thoenen H; Tranzer JP
    Annu Rev Pharmacol; 1973; 13():169-80. PubMed ID: 4576887
    [No Abstract]   [Full Text] [Related]  

  • 20. Importance of axonal transport of new amine granules for 3 H-noradrenaline retention capacity of adrenergic nerve terminals.
    Häggendal J; Dahlström A
    Acta Physiol Pol; 1973; 24(1):185-92. PubMed ID: 4351939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.